Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Evaluate Minimum Order Quantity (MOQ): Align supplier MOQ with your forecasted demand
Type 2 Diabetes: Glycaemic control, -cell function, and insulin sensitivity research
How GLP-1 drugs are reshaping health and consumer behaviour: key takeaways Metabolic dysfunction affects 88% of Americans, driving GLP-1 demand GLP-1 drugs used by 12% of Americans, likely underreported figures Originally for diabetes, now treating obesity and chronic conditions Over 100 trials underway, multi-agonists show enhanced weight loss Global uptake expected to rise as patents expire and access grows GLP-1 medications are no longer fringe theyre mainstream, and theyre reshaping everything from public health to consumer behaviour
In our dataset, race was not mutually exclusive, e.g., a subject can have the value 1 for being both White and Asian
Emily Thompson, Single mother (US)
